Get started
Author

Barbara Di Francesco

Observed names: B. DI Francesco, B. Di Francesco, DI FRANCESCO, BARBARA, Di Francesco, Barbara
ORCID: 0000-0002-4184-8601
Observed ORCID: 0000-0002-4184-8601
OpenAlex ID: A5026673108
NF-κB: A Druggable Target in Acute Myeloid Leukemia
2022 · Barbara Di Francesco, Daniela Verzella, et al. · Cancers · 66
PDF
NF-κB and mitochondria cross paths in cancer: mitochondrial metabolism and beyond
2019 · Daria Capece, Daniela Verzella, et al. · Seminars in Cell and Developmental Biology · 66
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis
2021 · Paola Di Benedetto, Piero Ruscitti, et al. · Arthritis Research & Therapy · 53
PDF
CD19.CAR T-cell–derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy
2025 · Paola Lanuti, Francesco Guardalupi, et al. · Blood Advances · 27
PDF
Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer
2022 · Davide Vecchiotti, Daniela Verzella, et al. · Cells · 16
PDF
Low Radiation Environment Switches the Overgrowth-Induced Cell Apoptosis Toward Autophagy
2021 · Mariafausta Fischietti, Emiliano Fratini, et al. · Frontiers in Public Health · 13
PDF
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation
2024 · Mauro Di Ianni, Carmine Liberatore, et al. · Cells · 3
PDF
Biochemical Methods to Analyze the Subcellular Localization of NF-κB Proteins Using Cell Fractionation
2021 · Davide Vecchiotti, Daniela Verzella, et al. · Methods in molecular biology · 2
Immunohistochemical Analysis of Expression, Phosphorylation, and Nuclear Translocation of NF-κB Proteins in Human Tissues
2021 · Davide Vecchiotti, Daniela Verzella, et al. · Methods in molecular biology · 2
Data from GADD45β Loss Ablates Innate Immunosuppression in Cancer
2023 · Daniela Verzella, Jason Bennett, et al.
Supplementary information from GADD45β Loss Ablates Innate Immunosuppression in Cancer
2023 · Daniela Verzella, Jason Bennett, et al.
PDF
Figure S6 from GADD45β Loss Ablates Innate Immunosuppression in Cancer
2023 · Daniela Verzella, Jason Bennett, et al.
PDF
Figure S5 from GADD45β Loss Ablates Innate Immunosuppression in Cancer
2023 · Daniela Verzella, Jason Bennett, et al.
Figure S7 from GADD45β Loss Ablates Innate Immunosuppression in Cancer
2023 · Daniela Verzella, Jason Bennett, et al.
PDF
Figure S4 from GADD45β Loss Ablates Innate Immunosuppression in Cancer
2023 · Daniela Verzella, Jason Bennett, et al.
Figure S3 from GADD45β Loss Ablates Innate Immunosuppression in Cancer
2023 · Daniela Verzella, Jason Bennett, et al.
Figure S2 from GADD45β Loss Ablates Innate Immunosuppression in Cancer
2023 · Daniela Verzella, Jason Bennett, et al.
PDF
Figure S1 from GADD45β Loss Ablates Innate Immunosuppression in Cancer
2023 · Daniela Verzella, Jason Bennett, et al.
PDF
Figure S5 from GADD45β Loss Ablates Innate Immunosuppression in Cancer
2023 · Daniela Verzella, Jason Bennett, et al.
PDF
Figure S4 from GADD45β Loss Ablates Innate Immunosuppression in Cancer
2023 · Daniela Verzella, Jason Bennett, et al.
PDF
Figure S1 from GADD45β Loss Ablates Innate Immunosuppression in Cancer
2023 · Daniela Verzella, Jason Bennett, et al.
Figure S6 from GADD45β Loss Ablates Innate Immunosuppression in Cancer
2023 · Daniela Verzella, Jason Bennett, et al.
Figure S3 from GADD45β Loss Ablates Innate Immunosuppression in Cancer
2023 · Daniela Verzella, Jason Bennett, et al.
PDF
Figure S2 from GADD45β Loss Ablates Innate Immunosuppression in Cancer
2023 · Daniela Verzella, Jason Bennett, et al.
Figure S7 from GADD45β Loss Ablates Innate Immunosuppression in Cancer
2023 · Daniela Verzella, Jason Bennett, et al.
Works count: 37
Citation count: 248
H-index: 6
I10-index: 6
Year
Topic
Type